Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,091 | 96,952 | 118,544 | 121,374 | 191,873 |
| Marketable Securities | 261,726 | 267,690 | 263,874 | 281,588 | 202,261 |
| Receivables | 18,861 | 28,082 | 32,549 | 37,500 | 27,022 |
| Other current assets | 23,003 | 9,352 | 6,848 | 8,717 | 7,179 |
| TOTAL | $389,202 | $415,976 | $436,639 | $465,424 | $446,877 |
| Non-Current Assets | |||||
| PPE Net | 141,573 | 141,685 | 140,906 | 138,815 | 135,264 |
| Investments And Advances | 141,709 | 200,560 | 234,594 | 279,073 | 370,659 |
| Other Non-Current Assets | 75,346 | 75,047 | 71,654 | 70,132 | 72,568 |
| TOTAL | $358,628 | $417,292 | $447,154 | $488,020 | $578,491 |
| Total Assets | $747,830 | $833,268 | $883,793 | $953,444 | $1,025,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,283 | 27,213 | 25,210 | 16,985 | 24,708 |
| Accrued Expenses | 31,709 | 46,794 | 44,462 | 47,014 | 48,423 |
| Other current liabilities | 49,728 | 48,601 | 44,365 | 41,089 | 41,352 |
| TOTAL | $112,334 | $130,434 | $123,548 | $114,556 | $119,937 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,311 | 1,829 | 5,903 | 6,636 | 3,333 |
| Other Non-Current Liabilities | 170,357 | 186,639 | 196,421 | 208,369 | 215,762 |
| TOTAL | $170,357 | $186,639 | $196,421 | $208,369 | $215,762 |
| Total Liabilities | $282,691 | $317,073 | $319,969 | $322,925 | $335,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,466 | 43,464 | 43,294 | 43,230 | 43,134 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -508,229 | -441,553 | -381,618 | -306,134 | -237,955 |
| Other shareholders' equity | -11,622 | -15,401 | -18,256 | -14,763 | -11,950 |
| TOTAL | $465,139 | $516,195 | $563,824 | $630,519 | $689,669 |
| Total Liabilities And Equity | $747,830 | $833,268 | $883,793 | $953,444 | $1,025,368 |